findmyKOL
Clinical trialNCT04597372RecruitingPhase 2Interventional

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Enrollment154Urinary Retention Postoperative
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Lindsay Turner, MD

    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • West Penn Hospital

    Pittsburgh, Pennsylvania, United States

    Lindsay Turner, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Nov 2021
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
20 Mar 2026
Registered enrollment
154
Registry id
NCT04597372

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.